“…In line with the mapping of the ligand, the sst receptors are widely expressed in the rodent brain with the following regional pattern: all layers of the cerebral cortex (sst 1 , sst 2a/b , sst 3 , sst 4 ), bed nucleus of the stria terminalis (sst 1 , sst 2a, b , sst 4 ), hippocampus (sst 1 , sst 2a, b , sst 3 , sst 4 ), basolateral amygdaloid nucleus (sst 1 , sst 2a/b , sst 3 , sst 4 ), medial amygdaloid nucleus (sst 1 , sst 2 , sst 3 ), ventromedial hypothalamic nucleus (sst 1 , sst 2 , sst 3 ), dorsomedial hypothalamic nucleus (sst 1 , sst 3 ), paraventricular nucleus (sst 2a , sst 3 ) and arcuate nucleus of the hypothalamus (sst 1 , sst 2a , sst 3 , sst 4 ), substantia nigra (sst 1 , sst 2a/b , sst 3 ), dorsal raphe nucleus (sst 1 , sst 2 , sst 3 ), locus coeruleus (sst 2 , sst 3 ), granular layer of the cerebellum (sst 1 , sst 2b , sst 3 , sst 4 , sst 5 ), dorsal motor nucleus of the vagus nerve (sst 2a, b , sst 4 , sst 5 ) and nucleus of the solitary tract (sst 1 , sst 2 , sst 3 ) (Schindler and Humphrey, 1999; Fehlmann et al, 2000; Schulz et al, 2000; Hannon et al, 2002b; Videau et al, 2003; Spary et al, 2008; Kumar, 2012). With regards to the truncated sst 5 variants, they show a distinct distribution with a high abundance of full length sst 5 in mouse hypothalamus and cerebellum followed by sst 5 TMD2 and sst 5 TMD1, whereas sst 5 TMD4 is not detectable (Hannon et al, 2002b; Cordoba-Chacon et al, 2010).…”